Skip to main content
. 2020 Jan 28;10:1332. doi: 10.1038/s41598-020-57930-x

Figure 3.

Figure 3

(A) CA19-9 values over all patients at baseline (before any therapy), after surgery (but before adjuvant chemotherapy), and at time point of recurrence are illustrated. CA19-9 negative patients are excluded. (B) Time interval between serological detection and evidence of recurrence in imaging in test set (red) and validation set (light blue).